Transcatheter Aortic Valve Replacement Market to Hit USD 8,862...

Transcatheter Aortic Valve Replacement Market to Hit USD 8,862 Million by 2030- MarkNtel

Δημοσιευμένα 2025-11-05 06:41:55

Global Transcatheter Aortic Valve Replacement Market: Key Dynamics, Size & Share Analysis

As per MarkNtel Advisors the Global Transcatheter Aortic Valve Replacement Market size was valued at around USD 4,121 million in 2024 and is projected to reach USD 8,862 million by 2030. Along with this, the market is estimated to grow at a CAGR of around 13.61% during the forecast period, i.e., 2025-30.

Global Transcatheter Aortic Valve Replacement Market Trend:

Advancement in Mechanism of Transcatheter Aortic Valve Replacement – The advancements in TAVR procedure and devices have surged lately, due to the optimized adjustment, precise diagnosis, better treatment, etc. The development of new technologies, such as balloon-expandable valve (BEV), and others, has surged lately due to the shift towards next-generation technology, enhanced post-surgery outcomes, easy deployment, and others. The compact size of the balloon-expandable valve mechanism results in convenient access to the heart arteries and veins in the future. The BEV is revolutionizing the market of TAVR, resulting in more than 50% of the TAVR surgeries on balloon-expandable mechanisms by the end of 2025. Meeting up with the trend and adapting to the growing need, numerous key companies, including Medtronic, Edwards Lifesciences, Abbott, etc., are investing in such technologies and further innovating in them.

Thus, the increasing need for safer, precise, future-prospective access to the arteries and components of the heart, and investments in the technologies, increases the acceptability of BEV in TAVR, hence boosting the market growth globally.

✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2026 to 2032, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

Explore the Insights – Download a Free Sample: https://www.marknteladvisors.com/query/request-sample/transcatheter-aortic-valve-replacement-market.html

Transcatheter Aortic Valve Replacement Market Systems Market Segmentation:

-By Procedure

Transfemoral- Market Size & Forecast 2020-2030, USD Million
Transapical- Market Size & Forecast 2020-2030, USD Million
Transaortic- Market Size & Forecast 2020-2030, USD Million

-By Mechanism

Balloon-expandable- Market Size & Forecast 2020-2030, USD Million
Self-expandable- Market Size & Forecast 2020-2030, USD Million

-By End User

Hospitals- Market Size & Forecast 2020-2030, USD Million
Ambulatory Surgical Centers- Market Size & Forecast 2020-2030, USD Million
Others- Market Size & Forecast 2020-2030, USD Million

-By Material

Nitinol- Market Size & Forecast 2020-2030, USD Million
Cobalt Chromium- Market Size & Forecast 2020-2030, USD Million
Stainless Steel- Market Size & Forecast 2020-2030, USD Million
Others- Market Size & Forecast 2020-2030, USD Million

Geographical Analysis of the Transcatheter Aortic Valve Replacement Market

-By Region

North America
South America
Europe
The Middle East and Africa
Asia-Pacific

North America is dominating the market by more than 43% market share. The key reasons contributing to the market growth are the presence of advanced technological solution providers, advanced and mature healthcare infrastructure, high prevalence of valve dysfunction disease, government support, etc.

Tap into future trends and opportunities shaping the Transcatheter Aortic Valve Replacement view the complete report: https://www.marknteladvisors.com/research-library/transcatheter-aortic-valve-replacement-market.html

Transcatheter Aortic Valve Replacement Market Recent Development:

2025: Abbott Laboratories received FDA approval for Tendyne™, a novel mitral valve replacement device designed for transcatheter deployment. This innovation eliminates the need for open-heart surgery, offering a safer option for high-risk mitral valve disease patients.
2024: Edwards Lifesciences acquired JC Medical, gaining access to its J-Valve transcatheter aortic valve replacement (TAVR) technology. The acquisition expanded Edwards’ structural heart portfolio, with JC Medical retaining exclusive rights for commercializing the technology in Greater China, while Edwards secured global development and distribution rights.

Report Delivery Format – Market research reports from MarkNtel Advisors are delivered in PDF, Excel, and PowerPoint formats. Once the payment is successfully processed, the report will be sent to your registered email within 24 hours.

Report Highlights Essential Insights for Strategic Decision-Making

Detailed market size, share, and forecast analysis
In-depth pricing trends and segment-wise cost evaluations
Key industry strategies, including innovation, partnerships, and acquisitions
Critical value chain analysis and stakeholder profiling
Regional import-export market insights and trade flow assessment
Thorough competitive benchmarking of top hearing aid manufacturers
Identification of new growth opportunities and niche market segments
Overview of market trends, drivers, and challenges shaping future demand

Some of the leading players in the Transcatheter Aortic Valve Replacement Market are:

Abbott Laboratories
Boston Scientific Corporation
Blue Sail Medical Co. Ltd.
Bracco SpA
Edward Lifesciences
JC Medical Inc.
JenaValve Techologies Inc.
Medtronic Plc
Meril Lifesciences
Venus Medtech
Jude Medical, Inc.
Coroneo Inc.
Thubrikar Aortic Valve Inc.
Others

Select a License That Matches Your Business Requirements with Instant Offer - https://www.marknteladvisors.com/pricing/transcatheter-aortic-valve-replacement-market.html

Research Methodology Summary

A systematic approach is used to ensure accurate market insights, combining both bottom-up and top-down methods. Data triangulation validates findings from multiple angles.

Key Steps:

Define objectives and research design
Collect data through surveys and interviews
Analyze and validate data using reliable tools
Forecast trends and deliver actionable insights

About us:

MarkNtel Advisors is a distinguished Industry Research Report Firm and Market Research Company offering comprehensive intelligence across the healthcare sector, covering pharmaceuticals, medical devices, healthcare IT, and biotechnology. Our team delivers high-precision Market Research Reports and Business Analysis at global, regional, and country levels to help organizations understand market access strategies, innovation trends, and regulatory frameworks. Using robust data methodologies and validated Market Forecast models, we provide insights that enhance decision-making and operational agility. Our expertise extends to Customized Market Research Reports that measure therapeutic performance, digital transformation, and patient-centric solutions. Through strategic Consulting Services, we empower healthcare companies, investors, and policymakers to quantify Revenue Impact, strengthen competitiveness, and accelerate sustainable growth within the dynamic global healthcare landscape.